Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

Pathways to Cures Roadmap was created by a number of MS representatives and was endorsed by more than 30 organizations.

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an ...

After years of caring for others, Auckland nurse Zazi Gohar faced her own health crisis when she was diagnosed with multiple ...

A woman with multiple sclerosis (MS) has become the first person in the UK to receive a new "game-changer" 10-minute ...

The study, which utilised data from the French MS Registry, Italian MS Register, and the global MSBase Registry, analysed the outcomes of 282 patients with paediatric-onset MS.

Subcutaneous administration of ocrelizumab was noninferior to intravenous infusion in the phase 3 OCARINA II trial.

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

Patients receiving chemotherapy in Lincolnshire can now have additional treatment to help reduce their hair loss. Many cancer ...

This roundup covers various health news highlights including the mpox outbreak in Africa and vaccine distribution issues, the ...

The seven-year MS-STAT study, which involved almost 1,000 patients over 31 sites across the UK, concluded that simvastatin is ...